Azithromycin Cas helu: 83905-01-5 Molecular Formula: C38H72N2O12
| Lae hehee | 115°C |
| ʻO ka mānoanoa | 1.18 g/cm³ |
| ka mahana mālama | ʻO ka lewa inert, lumi wela 2-8°C |
| hikiwawe | DMF: 16 mg/ml DMSO: 5 mg/mlm Ethanol: 16 mg/ml Ethanol:PBS(pH 7.2) (1:1): 0.50 mg/ml |
| hana ʻōpika | N/A |
| Ka nana aku | Pauda keʻokeʻo |
| Maemae | ≥98% |
Hāʻawi ʻo Manus Aktteva Biopharma LLP, kahi hui hoʻokele honua a me kahi mea hoʻolako o Azithromycin (CAS No.: 83905-01-5) hāʻawi no kāu mau koi o RND / Development nui a i ʻole nā mea kūʻai aku, e pili ana i ke kūlana o ka huahana.
DISCLAIMER: ʻOiai e hana ʻia nā mea a pau a e hana pū mākou i nā mea āpau inā e kū mai kekahi pilikia i ka wā o ka ʻimi ʻana, ʻaʻole hiki iā mākou ke kuleana no ka hoʻokō ʻole ʻana a i ʻole nā pilikia i ke kālepa e hiki mai ana, aia ma waho o kā mākou mana. i loko o ka māhele waiwai / papa inoa o ka papa inoa o nā lāʻau lapaʻau e hoʻokuʻu pololei ʻia mai nā kumu hana hana wale nō e kūʻē i ka loaʻa ʻana o ka ʻae hoʻokomo kumu i hoʻopuka ʻia e nā mana pili o ka ʻāina e lawe mai ana. nā kānāwai ma ka ʻāina a i ʻole ka honua.ʻO kā mākou mau moʻolelo lehulehu e kamaʻilio e pili ana i ko mākou hilinaʻi.ʻAʻole mākou e paipai a makemake paha e lilo i ʻāpana o kekahi hui pilikino a lehulehu paha e hōʻoia i kā mākou hoʻokō.
PATENTS ʻAʻole hāʻawi ʻia nā huahana i pale ʻia e nā patent kūpono no ke kūʻai aku ma nā ʻāina kahi i kūʻai ʻia ai ke kūʻai ʻana o ia mau huahana i kahi hōʻino patent a aia kona kuleana i ka mea kūʻai aku.Hāʻawi ʻia nā huahana i uhi ʻia e nā US Patents kūpono no ka hoʻohana ʻana i ka R&D e like me 35 USC 271 +A13(1)• ʻAʻole manaʻo ʻo Manus Aktteva Biopharma LLP i ke kuleana/kuleana inā hāʻawi ʻia me nā waiwai e hōʻino i ka waiwai o ka naʻauao ma kēlā me kēia ʻano. kuleana patent o kekahi kanaka.ʻAʻole hana ʻo Manus Aktteva Biopharma LLP i nā hōʻike a i ʻole nā hōʻoia o kēlā me kēia ʻano, hōʻike a i ʻole ka manaʻo, e pili ana i ke kumu a i ʻole ka hilinaʻi e pili ana i ka waiwai noʻonoʻo e komo pū ana nā patent i kāna huahana a i nā lawelawe no kekahi kumu.Hoʻomaopopo ʻo Manus Aktteva Biopharma LLP i nā mea kūʻai aku ʻaʻole e kūʻai aku i nā waiwai e hōʻino i ka waiwai naʻauao ma nā ʻano like ʻole e pili ana i nā kuleana patent o kēlā me kēia kanaka.Hoʻomaopopo ʻo Manus Aktteva Biopharma LLP i nā mea kūʻai mai ʻaʻole e hoʻohana a kūʻai i kekahi waiwai e hoʻokō ai i kahi huahana i hiki ke hana me ka ʻike ʻole i ka hōʻino ʻana i ka waiwai naʻauao ma nā ʻano like ʻole me nā kuleana patent o kēlā me kēia kanaka.
ʻO Azithromycin kahi erythromycin semi-synthetic, hoʻonui i ke apo i hana ʻia e kahi Beckmann rearrangement o ka erythromycin oxime a hoʻemi i ka imine ether, a ukali ʻia e ka methylation reductive.ʻO Azithromycin ka mua o nā azalides a ua hoʻolālā ʻia e hoʻomaikaʻi i ke kūpaʻa a me ka hapalua ola o ka erythromycin A, a me ka hoʻomaikaʻi ʻana i ka hana kūʻē i ka bacteria Gram negative.Mai kona loaʻa ʻana ma 1980 e Djokic a me nā hoa hana, ua hauʻoli ʻo azithromycin i ka kūleʻa therapeutic nui.
